期刊文献+

碘克沙醇全脑血管造影致迟发型过敏反应分析 被引量:7

Analysis of iodixanol-induced delayed hypersensitive reactions in patients undergoing digital subtraction angiography
原文传递
导出
摘要 目的:探讨全脑血管造影中使用碘克沙醇为对比剂时迟发型过敏反应的发生率及危险因素。方法:统计西安交通大学第二附属医院2016年1-10月235例以碘克沙醇为对比剂进行全脑血管造影的患者资料、碘对比剂信息、过敏反应发生情况,通过统计分析患者发生迟发型过敏反应的危险因素。结果:西安交通大学第二附属医院使用碘克沙醇进行全脑血管造影时,迟发型过敏反应的发生率为6.38%,年龄是发生迟发型过敏反应的危险因素(P<0.05)。结论:西安交通大学第二附属医院使用碘克沙醇为对比剂进行全脑血管造影时迟发型过敏反应发生率较高。 Objective: To investigate the incidence and risk factors of iodixanol-induced delayed hypersensitive reactions in patients undergoing digital subtraction angiography (DSA). Methods: This study was carried out in the Second Affiliated Hospital of Xi'an Jiaotong University. Totally 235 patients who used iodixanol as iodinated contrast media (ICM) for DSA were included from January to October 2016. Various information was recorded, including patient age, gender, risk factor (hypertension, diabetes mellitus, renal disease, cardiopulmonary disease, previous food and drug allergy, repeated administration of ICM, treatment with ACE inhibitors, β-blockers, or IL-2), iodixanol information (strengths, total dosage and administration), information of delayed hypersensitive reactions (occurrence time, clinical feature, outcome, et al). The incidence and risk factors of iodixanol-induced delayed hypersensitive reactions were analyzed using logistic regression analysis. Results: The incidence of iodixanol-induced delayed hypersensitive reactions was 6.38% in our hospital, and age (OR=0.937, P=0.007) was an independent risk factor for the reactions. Conclusion: The incidence of iodixanol-induced delayed hypersensitive reactions is high in our hospital, and age is an independent risk factor for the reactions.
出处 《临床药物治疗杂志》 2017年第4期58-60,共3页 Clinical Medication Journal
关键词 碘克沙醇 全脑血管造影 迟发型过敏反应 危险因素 iodixanol digital subtraction angiography delayed hypersensitive reactions independent risk factor
  • 相关文献

参考文献3

二级参考文献64

  • 1吴新民,薛张纲,王俊科,叶铁虎,赵晶.围术期过敏反应诊治的专家共识[J].中国继续医学教育,2011,3(10):129-130. 被引量:34
  • 2全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:714
  • 3慕朝伟,高润霖,陈纪林,杨跃进,乔树宾,姚民,秦学文,徐波,刘海波,吴永建,袁晋青,陈珏,李建军,戴军,尤士杰,窦克非,邱洪,王增武.非离子型碘造影剂的过敏样反应[J].中国循环杂志,2007,22(3):172-175. 被引量:45
  • 4ACR Manual on Contrast Media version 9. ACR Committee on Drugs and Contrast Media. 2013.
  • 5Solomon RJ, Natarajan MK, Doucet S, et al. Cardiac angiography in renally impaired patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation, 2007, 115:3189-3196.
  • 6ESUR Guidelinesversion 8. ESUR Contrast Media Safety Committee. 2012.
  • 7Lang DM, Alpern MB, Visintainer PF, et al. Elevated risk of anaphylactic reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders. Arch Intern Med, 1993, 153:2033-2040.
  • 8Chen Y, Hu S, Liu Y, et al. Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study. Eurlntervention, 2012, 22:830-838.
  • 9Wright RS, Anderson JL, Adams CD, et al. 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 2011, 123:2022-2060.
  • 10Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/ SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation, 2011, 124:e574-e651.

共引文献245

同被引文献63

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部